CHRONIC MYELOID LEUKEMIA PATIENTS WERE NOT DIFFERENT IN MOLECULAR RELAPSE AFTER STOPPING IMATINIB IN MR4 WHETHER RESIDUAL DISEASE WAS DETECTED OR NOT - WHEN ADJUSTING FOR NUMBER OF CONTROL TRANSCRIPTS

M. Pfirrmann, F-X Mahon, J. Guilhot, J. Richter, A. Almeida, J. J. Janssen, J. Mayer, P. Koskenvesa, P. Panayiotidis, U. Olsson-Stromberg, M. G. Berger, J. Diamond, H. Ehrencrona, V. Kairisto, K. Machova Polakova, M. C. Mueller, S. Mustjoki, A. Hochhaus, S. Saussele, H. Hjorth-Hansen

Tutkimustuotos: ArtikkelijulkaisuKonferenssiesitelmän abstraktiTutkimusvertaisarvioitu

Alkuperäiskielienglanti
LehtiHaematologica
Vuosikerta102
Sivut153-153
Sivumäärä1
ISSN0390-6078
TilaJulkaistu - 26 kesäkuuta 2017
Tapahtuma22nd Congress of the European-Hematology-Association - Madrid, Espanja
Kesto: 22 kesäkuuta 201725 kesäkuuta 2017

Lainaa tätä

Pfirrmann, M. ; Mahon, F-X ; Guilhot, J. ; Richter, J. ; Almeida, A. ; Janssen, J. J. ; Mayer, J. ; Koskenvesa, P. ; Panayiotidis, P. ; Olsson-Stromberg, U. ; Berger, M. G. ; Diamond, J. ; Ehrencrona, H. ; Kairisto, V. ; Polakova, K. Machova ; Mueller, M. C. ; Mustjoki, S. ; Hochhaus, A. ; Saussele, S. ; Hjorth-Hansen, H. / CHRONIC MYELOID LEUKEMIA PATIENTS WERE NOT DIFFERENT IN MOLECULAR RELAPSE AFTER STOPPING IMATINIB IN MR4 WHETHER RESIDUAL DISEASE WAS DETECTED OR NOT - WHEN ADJUSTING FOR NUMBER OF CONTROL TRANSCRIPTS. Julkaisussa: Haematologica. 2017 ; Vuosikerta 102. Sivut 153-153.
@article{a6db3390092f46caaa635e41da70ec15,
title = "CHRONIC MYELOID LEUKEMIA PATIENTS WERE NOT DIFFERENT IN MOLECULAR RELAPSE AFTER STOPPING IMATINIB IN MR4 WHETHER RESIDUAL DISEASE WAS DETECTED OR NOT - WHEN ADJUSTING FOR NUMBER OF CONTROL TRANSCRIPTS",
author = "M. Pfirrmann and F-X Mahon and J. Guilhot and J. Richter and A. Almeida and Janssen, {J. J.} and J. Mayer and P. Koskenvesa and P. Panayiotidis and U. Olsson-Stromberg and Berger, {M. G.} and J. Diamond and H. Ehrencrona and V. Kairisto and Polakova, {K. Machova} and Mueller, {M. C.} and S. Mustjoki and A. Hochhaus and S. Saussele and H. Hjorth-Hansen",
year = "2017",
month = "6",
day = "26",
language = "English",
volume = "102",
pages = "153--153",
journal = "Haematologica",
issn = "0390-6078",
publisher = "FERRATA STORTI FOUNDATION",

}

Pfirrmann, M, Mahon, F-X, Guilhot, J, Richter, J, Almeida, A, Janssen, JJ, Mayer, J, Koskenvesa, P, Panayiotidis, P, Olsson-Stromberg, U, Berger, MG, Diamond, J, Ehrencrona, H, Kairisto, V, Polakova, KM, Mueller, MC, Mustjoki, S, Hochhaus, A, Saussele, S & Hjorth-Hansen, H 2017, 'CHRONIC MYELOID LEUKEMIA PATIENTS WERE NOT DIFFERENT IN MOLECULAR RELAPSE AFTER STOPPING IMATINIB IN MR4 WHETHER RESIDUAL DISEASE WAS DETECTED OR NOT - WHEN ADJUSTING FOR NUMBER OF CONTROL TRANSCRIPTS', Haematologica, Vuosikerta 102, Sivut 153-153.

CHRONIC MYELOID LEUKEMIA PATIENTS WERE NOT DIFFERENT IN MOLECULAR RELAPSE AFTER STOPPING IMATINIB IN MR4 WHETHER RESIDUAL DISEASE WAS DETECTED OR NOT - WHEN ADJUSTING FOR NUMBER OF CONTROL TRANSCRIPTS. / Pfirrmann, M.; Mahon, F-X; Guilhot, J.; Richter, J.; Almeida, A.; Janssen, J. J.; Mayer, J.; Koskenvesa, P.; Panayiotidis, P.; Olsson-Stromberg, U.; Berger, M. G.; Diamond, J.; Ehrencrona, H.; Kairisto, V.; Polakova, K. Machova; Mueller, M. C.; Mustjoki, S.; Hochhaus, A.; Saussele, S.; Hjorth-Hansen, H.

julkaisussa: Haematologica, Vuosikerta 102, 26.06.2017, s. 153-153.

Tutkimustuotos: ArtikkelijulkaisuKonferenssiesitelmän abstraktiTutkimusvertaisarvioitu

TY - JOUR

T1 - CHRONIC MYELOID LEUKEMIA PATIENTS WERE NOT DIFFERENT IN MOLECULAR RELAPSE AFTER STOPPING IMATINIB IN MR4 WHETHER RESIDUAL DISEASE WAS DETECTED OR NOT - WHEN ADJUSTING FOR NUMBER OF CONTROL TRANSCRIPTS

AU - Pfirrmann, M.

AU - Mahon, F-X

AU - Guilhot, J.

AU - Richter, J.

AU - Almeida, A.

AU - Janssen, J. J.

AU - Mayer, J.

AU - Koskenvesa, P.

AU - Panayiotidis, P.

AU - Olsson-Stromberg, U.

AU - Berger, M. G.

AU - Diamond, J.

AU - Ehrencrona, H.

AU - Kairisto, V.

AU - Polakova, K. Machova

AU - Mueller, M. C.

AU - Mustjoki, S.

AU - Hochhaus, A.

AU - Saussele, S.

AU - Hjorth-Hansen, H.

PY - 2017/6/26

Y1 - 2017/6/26

M3 - Meeting Abstract

VL - 102

SP - 153

EP - 153

JO - Haematologica

JF - Haematologica

SN - 0390-6078

ER -